Company intelligence / Profile preview

Scarguard Labs

Great Neck, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Scarguard's lead products are commercially available and clinically proven, with its main scar treatment liquid demonstrating up to 75% scar reduction in an independent dermatology study. The company produces several over-the-counter drugs and dermatology-focused topicals with wide retail distribution, leveraging patented nanotechnology for scar management. All core programs are commercial. [1][3][5]

Therapeutic areas: HematologyDermatology
Modalities: Small moleculeBiologicDevice
Industry: Biotech

Beyond the preview

Go deeper on Scarguard Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scarguard Labs.

Explore the full profile